Short Interest in Celularity Inc. (NASDAQ:CELUW) Rises By 51.3%

Celularity Inc. (NASDAQ:CELUW) was the target of a significant growth in short interest in January. As of January 15th, there was short interest totaling 3,393 shares, a growth of 51.3% from the December 31st total of 2,243 shares. Based on an average daily volume of 2,351 shares, the days-to-cover ratio is currently 1.4 days. Based on an average daily volume of 2,351 shares, the days-to-cover ratio is currently 1.4 days.

Celularity Trading Down 48.9%

Shares of CELUW stock traded down $0.01 during trading on Friday, reaching $0.01. The company’s stock had a trading volume of 195,265 shares, compared to its average volume of 17,511. Celularity has a 1-year low of $0.01 and a 1-year high of $0.75. The stock’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.03.

Celularity Company Profile

Celularity, Inc is a clinical-stage biotechnology company headquartered in Florham Park, New Jersey, that specializes in the development and commercialization of allogeneic “off-the-shelf” cell therapies derived from postpartum placental cells. Leveraging a proprietary platform of placental- and umbilical-derived cells, the company seeks to deliver immune-modulatory, regenerative and anti-inflammatory treatments across oncology, immunology and other therapeutic areas. By harnessing the natural properties of placental cells, Celularity aims to overcome the limitations of autologous therapies and scale production to serve a broad patient population.

The company’s pipeline includes CYNK-001, an investigational natural killer (NK) cell therapy being evaluated for hematological malignancies and solid tumors, as well as other cell-based programs targeting viral infections and tissue repair.